- Home
- SKYE vs BRAG Comparison
SKYE vs BRAG Comparison
Compare SKYE & BRAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SKYE
- BRAG
- Stock Information
- Founded
- SKYE 2012
- BRAG 2018
- Country
- SKYE United States
- BRAG Canada
- Employees
- SKYE N/A
- BRAG N/A
- Industry
- SKYE Biotechnology: Pharmaceutical Preparations
- BRAG Office Equipment/Supplies/Services
- Sector
- SKYE Health Care
- BRAG Technology
- Exchange
- SKYE Nasdaq
- BRAG Nasdaq
- Market Cap
- SKYE 108.3M
- BRAG 114.3M
- IPO Year
- SKYE N/A
- BRAG N/A
- Fundamental
- Price
- SKYE $4.12
- BRAG $3.31
- Analyst Decision
- SKYE Buy
- BRAG Buy
- Analyst Count
- SKYE 6
- BRAG 2
- Target Price
- SKYE $18.67
- BRAG $7.50
- AVG Volume (30 Days)
- SKYE 166.3K
- BRAG 80.0K
- Earning Date
- SKYE 11-07-2024
- BRAG 11-14-2024
- Dividend Yield
- SKYE N/A
- BRAG N/A
- EPS Growth
- SKYE N/A
- BRAG N/A
- EPS
- SKYE N/A
- BRAG N/A
- Revenue
- SKYE N/A
- BRAG $109,522,641.00
- Revenue This Year
- SKYE N/A
- BRAG $10.73
- Revenue Next Year
- SKYE N/A
- BRAG $9.35
- P/E Ratio
- SKYE N/A
- BRAG N/A
- Revenue Growth
- SKYE N/A
- BRAG 4.64
- 52 Week Low
- SKYE $1.44
- BRAG $2.86
- 52 Week High
- SKYE $19.41
- BRAG $7.00
- Technical
- Relative Strength Index (RSI)
- SKYE 35.19
- BRAG 27.29
- Support Level
- SKYE $4.32
- BRAG $3.20
- Resistance Level
- SKYE $5.67
- BRAG $3.41
- Average True Range (ATR)
- SKYE 0.49
- BRAG 0.22
- MACD
- SKYE -0.17
- BRAG -0.09
- Stochastic Oscillator
- SKYE 2.65
- BRAG 25.86
About SKYE Skye Bioscience Inc. Common Stock
Skye Bioscience Inc is a pre-clinical pharmaceutical company located in San Diego, California. The company's clinical assets focus on the modulation of cannabinoid receptor 1 ("CB1") to provide novel treatments and alternatives for diseases caused by metabolic disorders, inflammation, fibrosis and neurodegeneration, such as obesity and glaucoma. The company's Phase 2 clinical candidates include nimacimab, a negative allosteric modulating antibody that inhibits peripheral CB1 receptors, currently being developed for the treatment of obesity and SBI-100 Ophthalmic Emulsion ("SBI-100 OE"), a CB1 agonist (activator), currently being developed for the treatment of glaucoma and ocular hypertension.
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.